Alexion

money scales

Fierce Pharma

Syntimmune shareholders win again over AZ, this time for $181M

A Delaware judge has sided with Syntimmune shareholders over AstraZeneca, granting a $181 million award on top of a $130 million decision last year.

Kevin Dunleavy Jun 12, 2025 11:40am

pivot change turnaround direction walk away

AstraZeneca CEO defends 'fantastic' Alexion buy as halts drug

Feb 6, 2025 6:45am

scrapheap

AZ licenses discarded rare disease drug to Monopar Therapeutics

Oct 24, 2024 2:54pm

Illustration connected puzzle pieces with the acronym MA

AstraZeneca inks $800M buyout to snag phase 3 rare disease drug

Mar 14, 2024 9:47am

spring slinky competition overtake crush absorb

SpringWorks eyes AstraZeneca's Koselugo market with phase 2 data

Nov 16, 2023 10:59am

Graphic of a spaceship landing on Mars surface

Voyager asset lands on planet Alexion after Pfizer handoff

Nov 6, 2023 4:01pm